I said if they did an RS I expected on Friday this week but it had to be into a news event. That news event is either good AACR data and or FDA news as we must be around the 30 day response timeline that FDA have to reply after Advaxis submitted information.
I was highlighting that there is potential for shares to become scarce and with only 5 million or so shares that is pretty scarce if good news follows.
This is just a gamble on manipulation. They still don't have a partner and are obviously not seeing anything short term. So sad.
BINGO! Hope with the tiny float and news coming that they can get the price up to $9-10, then drop the dilution at say $7 a share is the BEST we can hope for near term.